Balqis Khoirunnisa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Balqis Khoirunnisa has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Shania Santoso
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University , Radioputero Building 2nd Floor, Kesehatan Street No.1, Mlati, Sleman, Special Region of Yogyakarta 55281
1 shared publication - Dyah Wulan Anggrahini
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/ Sardjito General Hospital, Yogyakarta, Indonesia
1 shared publication - Helvina Vika Etami
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University , Radioputero Building 2nd Floor, Kesehatan Street No.1, Mlati, Sleman, Special Region of Yogyakarta 55281
1 shared publication - Muhamad Taufik Ismail
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing Gadjah Mada University, Sleman, 55281
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (5)
Percutaneous pharmacomechanical thrombectomy using AngioJet® for acute limb ischaemia due to infective endocarditis: a case report
Background: Acute limb ischaemia (ALI) is a potential thromboembolic complication of infective endocarditis (IE), which requires immediate attention to prevent permanent ischaemic injury and loss of limb. Given the complex haemostatic dysregulation inherent to IE, balancing the thrombotic and haemorrhagic risk is critical in its management. Case summary: This study follows a patient diagnosed with ALI Rutherford IIa due to infective endocarditis from Streptococcus sanguinis infection. The patient was successfully treated with percutaneous mechanical thrombectomy using AngioJet®. Angio graphic evaluation showed restored distal arterial flow with no residual thrombus. At follow-up, the patient had returned to their daily activities without complaints. Discussion: ALI secondary to IE is traditionally treated with surgical embolectomy. However, endovascular techniques have emerged as an increasingly preferred first-line therapy, offering comparable clinical efficacy to open surgery alongside enhanced postoperative recovery. To our knowledge, this case represents the first reported use of AngioJet® percutaneous pharmacomechanical thrombectomy for ALI caused by infective endocarditis. Despite the success observed in this particular patient, this approach should remain limited to carefully selected cases until further evidence on its safety and efficacy is available.
- 30 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (5)
Open AccessPercutaneous pharmacomechanical thrombectomy using AngioJet® for acute limb ischaemia due to infective endocarditis: a case report
Background: Acute limb ischaemia (ALI) is a potential thromboembolic complication of infective endocarditis (IE), which requires immediate attention to prevent permanent ischaemic injury and loss of limb. Given the complex haemostatic dysregulation inherent to IE, balancing the thrombotic and haemorrhagic risk is critical in its management. Case summary: This study follows a patient diagnosed with ALI Rutherford IIa due to infective endocarditis from Streptococcus sanguinis infection. The patient was successfully treated with percutaneous mechanical thrombectomy using AngioJet®. Angio graphic evaluation showed restored distal arterial flow with no residual thrombus. At follow-up, the patient had returned to their daily activities without complaints. Discussion: ALI secondary to IE is traditionally treated with surgical embolectomy. However, endovascular techniques have emerged as an increasingly preferred first-line therapy, offering comparable clinical efficacy to open surgery alongside enhanced postoperative recovery. To our knowledge, this case represents the first reported use of AngioJet® percutaneous pharmacomechanical thrombectomy for ALI caused by infective endocarditis. Despite the success observed in this particular patient, this approach should remain limited to carefully selected cases until further evidence on its safety and efficacy is available.